Regencell Bioscience Holdings Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.53%161.060.7%$1261.68m
LLYEli Lilly & Co. -0.74%330.501.1%$1097.94m
ABBVAbbVie, Inc. -0.59%139.461.9%$855.46m
PFEPfizer Inc. -1.36%42.500.9%$792.27m
BMYBristol-Myers Squibb Co. 0.18%70.371.0%$753.18m
MRKMerck & Co., Inc. 0.89%88.220.7%$703.88m
AZNAstraZeneca Plc 1.93%55.971.0%$393.65m
ALNYAlnylam Pharmaceuticals, Inc. -1.89%198.558.2%$220.58m
GSKGSK Plc 0.92%30.280.3%$210.46m
NVSNovartis AG -0.18%75.910.2%$200.56m
HZNPHorizon Therapeutics Plc -2.67%66.085.4%$183.67m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -3.04%335.503.9%$178.73m
SRPTSarepta Therapeutics, Inc. -1.90%112.6412.4%$139.04m
NVONovo Nordisk A/S -1.14%104.610.1%$131.59m

Company Profile

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.